Sfoglia per Rivista HAEMATOLOGICA
IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221)
2019-01-01 Amato, T.; Granai, M.; Leoncini, L.; Bellan, C.
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study
2007-01-01 Leoncini, Lorenzo; Rondoni, M; Arpinati, M; Paolini, S; Candoni, A; Fanin, R; Messa, E; Pirrotta, MARIA TERESA; Lauria, F.; Visani, G; Alberti, D; Rancati, F; Vinaccia, V; Russo, D; Saglio, G; Baccarani, M; Martinelli, G
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification
2017-01-01 Sutton, Lesley Ann; Hadzidimitriou, Anastasia; Baliakas, Panagiotis; Agathangelidis, Andreas; Langerak, Anton W; Stilgenbauer, Stephan; Pospisilova, Sarka; Davis, Zadie; Forconi, Francesco; Davi, Frederic; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome
2019-01-01 Benagiano, Marisa; Borghi, Maria Orietta; Romagnoli, Jacopo; Mahler, Michael; Della Bella, Chiara; Grassi, Alessia; Capitani, Nagaja; Emmi, Giacomo; Troilo, Arianna; Silvestri, Elena; Emmi, Lorenzo; Alnwaisri, Heba; Bitetti, Jacopo; Tapinassi, Simona; Prisco, Domenico; Baldari, Cosima; Meroni, Pier Luigi; D'Elios, Mario Milco
Intracytoplasmatic and intranuclear filamentous inclusions in a case of acute monocytic leukemia
1986-01-01 Leoncini, L.; Del Vecchio, M. T.; de Santi, M. M.; Cantore, M.; Tarantino, C.
Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?
2002-01-01 Bocchia, M.; Gentili, S.; Lauria, F.
Localized orbital lymphoma
1997-01-01 Galieni, P.; Polito, E.; Leccisotti, A.; Marotta, G.; Lasi, S.; Bigazzi, C.; Bucalossi, A.; Frezza, G.; Lauria, F.
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: The GIMEMA CML Working Party experience after a 7-year follow-up
2009-01-01 Palandri, Francesca; Castagnetti, Fausto; Alimena, Giuliana; Testoni, Nicoletta; Breccia, Massimo; Luatti, Simona; Rege Cambrin, Giovanna; Stagno, Fabio; Specchia, Giorgina; Martino, Bruno; Levato, Luciano; Merante, Serena; Liberati, Anna Maria; Pane, Fabrizio; Saglio, Giuseppe; Alberti, Daniele; Martinelli, Giovanni; Baccarani, Michele; Rosti, Gianantonio; GIMEMA CML Working, Party; Bocchia, Monica
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype
1998-01-01 Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F.
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype
1998-01-01 Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F.
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia
2015-01-01 Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Levato, Luciano; D’Adda, Mariella; Stagno, Fabio; Tiribelli, Mario; Salvucci, Marzia; Fava, Carmen; Martino, Bruno; Cedrone, Michele; Bocchia, Monica; Trabacchi, Elena; Cavazzin, Francesco; Usala, Emilio; Rossi, Antonella Russo; Bochicchio, Maria Teresa; Soverini, Simona; Alimena, Giuliana; Cavo, Michele; Pane, Fabrizio; Martinelli, Giovanni; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio
Low dose rituximab shares similar activity but slower timing of response than standard dose in patients with immune thrombocytopenia.
2007-01-01 Zaja, F; Battista, Ml; Pirrotta, Mt; Calmieri, S; Montagna, M; Marini, L; Cavallin, M; Bocchia, Monica; Defina, M; Ippoliti, M; Ferrara, F; Patriarca, F; Avanzino, Ma; Ragazzi, M; Fanin, R.
Low-dose fludarabine and cyclophosohamide in elderly patients with B-cell chronic lymphocytic leukemia refractory in conventional theraphy
2000-01-01 Marotta, G.; Bigazzi, C.; Lenoci, M.; Tozzi, M.; Bocchia, M.; Lauria, F.
Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC)
2003-01-01 Bocchia, M-; Gentili, S.; Forconi, F.; LE NOCI, M.; Tozzi, M.; Lauria, F.
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
2008-01-01 Zaja, Francesco; Battista, Marta Lisa; Pirrotta, Maria Teresa; Palmieri, Salvatore; Montagna, Michela; Vianelli, Nicola; Marin, Luciana; Cavallin, Margherita; Bocchia, Monica; Defina, Marzia; Ippoliti, Micaela; Ferrara, Felicetto; Patriarca, Francesca; Avanzini, Maria Antonietta; Regazzi, Mario; Baccarani, Michele; Isola, Miriam; Soldano, Franca; Fanin, Renato
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement
2015-01-01 Girmenia, Corrado; Viscoli, Claudio; Piciocchi, Alfonso; Cudillo, Laura; Botti, Stefano; Errico, Antonio; Sarmati, Loredana; Ciceri, Fabio; Locatelli, Franco; Giannella, Maddalena; Bassetti, Matteo; Tascini, Carlo; Lombardini, Letizia; Majolino, Ignazio; Farina, Claudio; Luzzaro, Francesco; Rossolini, GIAN MARIA; Rambaldi, Alessandro
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study
2002-01-01 Cavo, Michele; Benni, Monica; Ronconi, Sonia; Fiacchini, Mauro; Gozzetti, Alessandro; Zamagni, Elena; Cellini, Claudia; Tosi, Patrizia; Baccarani, Michele; Tura, Sante
Metabolismo purinico sintesi de novo in linfociti umani di sangue periferico
1989-01-01 Tabucchi, Antonella; Vannoni, Daniela; Porcelli, Brunetta; Di Stefano, A.; Pizzichini, M.; Leoncini, Roberto; Dispensa, E.; Marinello, E.
MN (N=Novatrone) COP-B therapy on higher and intermediated grade non-Hodgkins' lymphoma: An alternative to MA (A=Adriamycin) COP-B
1991-01-01 Mazza, P.; Bocchia, M.; Zanchini, R.; Gherlinzoni, F.; Zinzani, P. L.; Pileri, S.; Tura, S.
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.
2012-01-01 S., Ferrero; D., Capello; M., Svaldi; M., Boi; D., Gatti; D., Drandi; D., Rossi; S., Barbiero; B., Mantoan; E., Mantella; M., Zanni; P., Ghione; A., Larocca; R., Passera; F., Bertoni; V., Gattei; Forconi, Francesco; L., Laurenti; G. D., Poeta; R., Marasca; S., Cortelazzo; G., Gaidano; A., Palumbo; M., Boccadoro; M., Ladetto
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221) | 1-gen-2019 | Amato, T.; Granai, M.; Leoncini, L.; Bellan, C. | - | |
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study | 1-gen-2007 | Leoncini, Lorenzo; Rondoni, M; Arpinati, M; Paolini, S; Candoni, A; Fanin, R; Messa, E; Pirrotta, MARIA TERESA; Lauria, F.; Visani, G; Alberti, D; Rancati, F; Vinaccia, V; Russo, D; Saglio, G; Baccarani, M; Martinelli, G | - | |
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification | 1-gen-2017 | Sutton, Lesley Ann; Hadzidimitriou, Anastasia; Baliakas, Panagiotis; Agathangelidis, Andreas; Langerak, Anton W; Stilgenbauer, Stephan; Pospisilova, Sarka; Davis, Zadie; Forconi, Francesco; Davi, Frederic; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas | - | |
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome | 1-gen-2019 | Benagiano, Marisa; Borghi, Maria Orietta; Romagnoli, Jacopo; Mahler, Michael; Della Bella, Chiara; Grassi, Alessia; Capitani, Nagaja; Emmi, Giacomo; Troilo, Arianna; Silvestri, Elena; Emmi, Lorenzo; Alnwaisri, Heba; Bitetti, Jacopo; Tapinassi, Simona; Prisco, Domenico; Baldari, Cosima; Meroni, Pier Luigi; D'Elios, Mario Milco | - | |
Intracytoplasmatic and intranuclear filamentous inclusions in a case of acute monocytic leukemia | 1-gen-1986 | Leoncini, L.; Del Vecchio, M. T.; de Santi, M. M.; Cantore, M.; Tarantino, C. | - | |
Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia? | 1-gen-2002 | Bocchia, M.; Gentili, S.; Lauria, F. | - | |
Localized orbital lymphoma | 1-gen-1997 | Galieni, P.; Polito, E.; Leccisotti, A.; Marotta, G.; Lasi, S.; Bigazzi, C.; Bucalossi, A.; Frezza, G.; Lauria, F. | - | |
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: The GIMEMA CML Working Party experience after a 7-year follow-up | 1-gen-2009 | Palandri, Francesca; Castagnetti, Fausto; Alimena, Giuliana; Testoni, Nicoletta; Breccia, Massimo; Luatti, Simona; Rege Cambrin, Giovanna; Stagno, Fabio; Specchia, Giorgina; Martino, Bruno; Levato, Luciano; Merante, Serena; Liberati, Anna Maria; Pane, Fabrizio; Saglio, Giuseppe; Alberti, Daniele; Martinelli, Giovanni; Baccarani, Michele; Rosti, Gianantonio; GIMEMA CML Working, Party; Bocchia, Monica | - | |
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype | 1-gen-1998 | Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F. | - | |
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype | 1-gen-1998 | Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F. | - | |
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia | 1-gen-2015 | Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Levato, Luciano; D’Adda, Mariella; Stagno, Fabio; Tiribelli, Mario; Salvucci, Marzia; Fava, Carmen; Martino, Bruno; Cedrone, Michele; Bocchia, Monica; Trabacchi, Elena; Cavazzin, Francesco; Usala, Emilio; Rossi, Antonella Russo; Bochicchio, Maria Teresa; Soverini, Simona; Alimena, Giuliana; Cavo, Michele; Pane, Fabrizio; Martinelli, Giovanni; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio | - | |
Low dose rituximab shares similar activity but slower timing of response than standard dose in patients with immune thrombocytopenia. | 1-gen-2007 | Zaja, F; Battista, Ml; Pirrotta, Mt; Calmieri, S; Montagna, M; Marini, L; Cavallin, M; Bocchia, Monica; Defina, M; Ippoliti, M; Ferrara, F; Patriarca, F; Avanzino, Ma; Ragazzi, M; Fanin, R. | - | |
Low-dose fludarabine and cyclophosohamide in elderly patients with B-cell chronic lymphocytic leukemia refractory in conventional theraphy | 1-gen-2000 | Marotta, G.; Bigazzi, C.; Lenoci, M.; Tozzi, M.; Bocchia, M.; Lauria, F. | - | |
Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC) | 1-gen-2003 | Bocchia, M-; Gentili, S.; Forconi, F.; LE NOCI, M.; Tozzi, M.; Lauria, F. | - | |
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura | 1-gen-2008 | Zaja, Francesco; Battista, Marta Lisa; Pirrotta, Maria Teresa; Palmieri, Salvatore; Montagna, Michela; Vianelli, Nicola; Marin, Luciana; Cavallin, Margherita; Bocchia, Monica; Defina, Marzia; Ippoliti, Micaela; Ferrara, Felicetto; Patriarca, Francesca; Avanzini, Maria Antonietta; Regazzi, Mario; Baccarani, Michele; Isola, Miriam; Soldano, Franca; Fanin, Renato | - | |
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement | 1-gen-2015 | Girmenia, Corrado; Viscoli, Claudio; Piciocchi, Alfonso; Cudillo, Laura; Botti, Stefano; Errico, Antonio; Sarmati, Loredana; Ciceri, Fabio; Locatelli, Franco; Giannella, Maddalena; Bassetti, Matteo; Tascini, Carlo; Lombardini, Letizia; Majolino, Ignazio; Farina, Claudio; Luzzaro, Francesco; Rossolini, GIAN MARIA; Rambaldi, Alessandro | - | |
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study | 1-gen-2002 | Cavo, Michele; Benni, Monica; Ronconi, Sonia; Fiacchini, Mauro; Gozzetti, Alessandro; Zamagni, Elena; Cellini, Claudia; Tosi, Patrizia; Baccarani, Michele; Tura, Sante | - | |
Metabolismo purinico sintesi de novo in linfociti umani di sangue periferico | 1-gen-1989 | Tabucchi, Antonella; Vannoni, Daniela; Porcelli, Brunetta; Di Stefano, A.; Pizzichini, M.; Leoncini, Roberto; Dispensa, E.; Marinello, E. | - | |
MN (N=Novatrone) COP-B therapy on higher and intermediated grade non-Hodgkins' lymphoma: An alternative to MA (A=Adriamycin) COP-B | 1-gen-1991 | Mazza, P.; Bocchia, M.; Zanchini, R.; Gherlinzoni, F.; Zinzani, P. L.; Pileri, S.; Tura, S. | - | |
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes. | 1-gen-2012 | S., Ferrero; D., Capello; M., Svaldi; M., Boi; D., Gatti; D., Drandi; D., Rossi; S., Barbiero; B., Mantoan; E., Mantella; M., Zanni; P., Ghione; A., Larocca; R., Passera; F., Bertoni; V., Gattei; Forconi, Francesco; L., Laurenti; G. D., Poeta; R., Marasca; S., Cortelazzo; G., Gaidano; A., Palumbo; M., Boccadoro; M., Ladetto | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile